Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
18 Results Found
FDA withdraws accelerated approval of myeloma drug
The Food and Drug Administration Feb. 23 withdrew approval of Pepaxto (melphalan flufenamide), a drug once used with dexamethasone to treat certain U.S. patients with multiple myeloma, because a post-approval trial did not show it safe or effective.
AHA comments on proposed AHRQ initiative to advance patient safety
AHA submitted comments on how the Agency for Healthcare Research and Quality can best support the field in advancing patient safety through an action alliance, which the agency is launching in partnership with health care systems and patient safety advocates
FDA announces recall of Abbott imaging catheter
Abbott has recalled certain Dragonfly OpStar imaging catheters because a marker band may remain in the patient after use.
AHA urges FTC to investigate certain pharmacy benefit manager practices
AHA today urged the FTC to scrutinize commercial health plans that steer patients to third-party specialty pharmacies in which they have a financial interest.
FDA issues update on COVID-19 treatments, hemodialysis machine risk
FDA issues updates on a COVID-19 monoclonal antibody and antiviral pill, and certain Fresenius Medical Care hemodialysis machines.
FDA: Medtronic heart device could malfunction
Medtronic this week alerted health care providers to a defect in its Heartware Ventricular Assist Device System that may cause the internal pump to malfunction.
'Take Back Day' Saturday to dispose safely of prescription drugs
DEA offers posters and other materials to help hospitals and other partners promote the event in their community.
FDA alerts providers to airway device safety risk
The agency has received reports describing serious adverse events and deaths after ventilation failure using silicone-based electromyogram endotracheal tubes.
FDA issues duodenoscope safety recommendations
The agency recommends health care facilities that still use fixed endcap duodenoscopes complete their transition to newer models that can lower infection risks.
FDA alerts providers to endoscope recall, reprocessing change
The Food and Drug Administration yesterday alerted health care providers to a recall and change in reprocessing methods for certain urological endoscopes made by Karl Storz.